In conclusion, Clcn3 deficiency ameliorates HFD-induced obesity, meanwhile, improves glucolipid metabolism disorders, and the impairment of insulin sensitivity, which may be because of the AMPK-Ucp1 axis. Here, INS is linked to obesity disorder.